Compare Divis Laboratories with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ALEMBIC LTD - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ALEMBIC LTD DIVIS LABORATORIES/
ALEMBIC LTD
 
P/E (TTM) x 32.4 64.3 50.4% View Chart
P/BV x 7.3 2.3 320.1% View Chart
Dividend Yield % 0.6 0.4 137.4%  

Financials

 DIVIS LABORATORIES   ALEMBIC LTD
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-18
ALEMBIC LTD
Mar-18
DIVIS LABORATORIES/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,14272 1,585.8%   
Low Rs53334 1,572.6%   
Sales per share (Unadj.) Rs146.64.7 3,118.5%  
Earnings per share (Unadj.) Rs33.06.1 541.3%  
Cash flow per share (Unadj.) Rs38.46.2 614.9%  
Dividends per share (Unadj.) Rs10.000.20 5,000.0%  
Dividend yield (eoy) %1.20.4 316.1%  
Book value per share (Unadj.) Rs222.840.7 548.0%  
Shares outstanding (eoy) m265.47267.03 99.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.711.3 50.7%   
Avg P/E ratio x25.38.7 292.2%  
P/CF ratio (eoy) x21.88.5 257.2%  
Price / Book Value ratio x3.81.3 288.6%  
Dividend payout %30.33.3 923.8%   
Avg Mkt Cap Rs m222,31814,139 1,572.3%   
No. of employees `00010.8NA-   
Total wages/salary Rs m4,561207 2,198.9%   
Avg. sales/employee Rs Th3,616.0NM-  
Avg. wages/employee Rs Th423.8NM-  
Avg. net profit/employee Rs Th814.9NM-  
INCOME DATA
Net Sales Rs m38,9151,255 3,100.3%  
Other income Rs m1,134370 306.4%   
Total revenues Rs m40,0491,625 2,464.0%   
Gross profit Rs m12,617111 11,356.5%  
Depreciation Rs m1,42538 3,769.6%   
Interest Rs m132 782.4%   
Profit before tax Rs m12,313442 2,787.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,54324 14,794.2%   
Profit after tax Rs m8,7701,630 538.1%  
Gross profit margin %32.48.9 366.3%  
Effective tax rate %28.85.4 530.8%   
Net profit margin %22.5129.8 17.4%  
BALANCE SHEET DATA
Current assets Rs m45,3511,867 2,429.0%   
Current liabilities Rs m6,507591 1,100.7%   
Net working cap to sales %99.8101.6 98.2%  
Current ratio x7.03.2 220.7%  
Inventory Days Days12794 134.4%  
Debtors Days Days9574 129.4%  
Net fixed assets Rs m21,1601,791 1,181.5%   
Share capital Rs m531534 99.4%   
"Free" reserves Rs m58,62510,324 567.9%   
Net worth Rs m59,15610,858 544.8%   
Long term debt Rs m041 0.0%   
Total assets Rs m67,83211,591 585.2%  
Interest coverage x926.8260.9 355.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.1 529.8%   
Return on assets %12.914.1 92.0%  
Return on equity %14.815.0 98.8%  
Return on capital %20.815.2 137.2%  
Exports to sales %01.5 0.0%   
Imports to sales %21.821.0 103.9%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs m8,485263 3,222.1%   
Fx inflow Rs m32,35919 166,799.0%   
Fx outflow Rs m9,042264 3,427.5%   
Net fx Rs m23,317-244 -9,539.6%   
CASH FLOW
From Operations Rs m7,759236 3,290.3%  
From Investments Rs m-4,783-224 2,135.3%  
From Financial Activity Rs m-3,142-27 11,810.5%  
Net Cashflow Rs m-166-15 1,121.6%  

Share Holding

Indian Promoters % 52.0 64.0 81.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 0.2 5,900.0%  
FIIs % 19.0 9.7 195.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 26.1 65.9%  
Shareholders   31,796 54,701 58.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA  PFIZER  ALKEM LABORATORIES  ORCHID PHARMA LTD  SANOFI INDIA  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Sep 13, 2019 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS